Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)

China flag China · Delayed Price · Currency is CNY
43.17
-0.32 (-0.74%)
Feb 13, 2026, 3:04 PM CST
Market Cap39.68B +117.7%
Revenue (ttm)928.01M -12.0%
Net Income-301.59M
EPS-0.29
Shares Out919.06M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume20,368,804
Average Volume18,752,964
Open43.49
Previous Close43.49
Day's Range42.53 - 44.65
52-Week Range15.75 - 71.71
Beta0.21
RSI27.54
Earnings DateApr 25, 2026

About SHE:300255

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. The company offers crude heparin sodium, heparin sodium API, heparin sodium injections, low molecular weight heparin calcium injections, enoxaparin sodium injections, nandroparin calcium injection, dalteparin sodium API and injections, and other products. The company was found... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 1,254
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300255
Full Company Profile

Financial Performance

In 2024, SHE:300255's revenue was 1.03 billion, a decrease of -26.92% compared to the previous year's 1.41 billion. Losses were -249.48 million, -79.88% less than in 2023.

Financial Statements